Courtney Anne Schreiber
Stuart and Emily B.H. Mudd Professor in Human Behavior and Reproduction
Attending in Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Department of Obstetrics and Gynecology, Philadelphia, PA
Division Chief, Family Planning, Department of Obstetrics and Gynecology, Penn Medicine
Founder and Director, PEACE, The Pregnancy Early Access Center
Co-Director, Penn Promotes Research on Sex and Gender in Health
Research Director, Building Interdisciplinary Research Careers in Women's Health K-12 Program, Perelman School of Medicine, University of Pennsylvania
Senior Fellow, Leonard Davis Institute of Health Economics (LDI Amplify dissemination training program, 2021)
Human Stem Cell Research Advisory Committee Member, University of Pennsylvania (Office of the Vice Provost)
Executive Director, FOCUS on Health and Leadership for Women
Lead, Post-Roe Working Group, Penn Medicine
Lead, Elevating Women's Health, OBGYN Strategic Plan, Penn Medicine
Member, Search committee Vice Dean/Vice President of Inclusion, Diversity and Equity, Penn Medicine/PSOM
Penn Medicine BioBank Steering Committee Member, Penn Medicine
Department: Obstetrics and Gynecology
Contact information
Department of Obstetrics and Gynecology
3737 Market Street, 12th floor
Philadelphia, PA 19104
3737 Market Street, 12th floor
Philadelphia, PA 19104
Office: 215-615-6531
Fax: 215-615-5319
Fax: 215-615-5319
Education:
B.A. (Religion )
Columbia College, Columbia University, New York NY, 1993.
OTH (Postbaccalaurate Premedical Program)
University of Pennsylvania, Philadelphia, PA, 1995.
M.D.
New York University School of Medicine, New York, NY, 1999.
M.P.H. (Public Health )
University of Pittsburgh, Graduate School of Public Health, Epidemiology Track, Pittsburgh, PA, 2005.
B.A. (Religion )
Columbia College, Columbia University, New York NY, 1993.
OTH (Postbaccalaurate Premedical Program)
University of Pennsylvania, Philadelphia, PA, 1995.
M.D.
New York University School of Medicine, New York, NY, 1999.
M.P.H. (Public Health )
University of Pittsburgh, Graduate School of Public Health, Epidemiology Track, Pittsburgh, PA, 2005.
Post-Graduate Training
Resident, Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1999-2003.
Fellow, Contraceptive Research and Family Planning, University of Pittsburgh, Dept of Obstetrics, Gynecology and Reproductive Sciences, Pittsburgh, PA, 2003-2005.
Leading Success Certificate Program, Office of Organization Effectiveness, Perelman School of Medicine , 2013-2013.
Dr. Edward S. Cooper Leadership Development Program., The Wharton School, University of Pennsylvania, 2023-2023.
Resident, Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1999-2003.
Fellow, Contraceptive Research and Family Planning, University of Pittsburgh, Dept of Obstetrics, Gynecology and Reproductive Sciences, Pittsburgh, PA, 2003-2005.
Leading Success Certificate Program, Office of Organization Effectiveness, Perelman School of Medicine , 2013-2013.
Dr. Edward S. Cooper Leadership Development Program., The Wharton School, University of Pennsylvania, 2023-2023.
Certifications
Obstetrics and Gynecology, American Board of Obstetrics and Gynecology, 2007.
Complex Family Planning, American Board of Obstetrics and Gynecology, 2022.
Permanent linkObstetrics and Gynecology, American Board of Obstetrics and Gynecology, 2007.
Complex Family Planning, American Board of Obstetrics and Gynecology, 2022.
Description of Research Expertise
Clinical TrialsReproductive Science
Health Policy Research
Reproductive Epidemiology
Contraceptive Technology Development
Sex and Gender Disaggregated Research
Description of Clinical Expertise
Family PlanningMiscarriage
Abortion
Contraception
Description of Other Expertise
Reproductive Health Advocacy and Policy. I have served as an expert witness in over 20 legal cases related to abortion access and reproductive health. My specific areas of contribution include maintaining access to mifepristone and medication abortion.Selected Publications
Brown JE, Creinin MD, Wu H, Hubacher D, Schreiber CA, Kaneshiro B, Nanda K, Blithe DL: Menstrual cup use and intrauterine device expulsion in a copper intrauterine device randomized trial. Contraception 134:110415, Jun 2024.Jensen JT, Edelman A, Westhoff CL, Schreiber CA, Archer DF, Teal S, Thomas M, Brown J, Blithe DL: Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial. Contraception 24:110475, Apr 2024.
Mauck C, Thurman A, Jensen JT, Schreiber CA, Baker J, Hou MY, Chavoustie S, Dart C, Wu H, Zack N, Hatheway J, Friend D: Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive. Contraception 132:110373, Apr 2024.
Gilmore EV, Russell LB, Harvie HS, Schreiber CA: Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study. Contraception 20:110468, Apr 2024.
Edelman A, Jensen JT, Brown J, Thomas M, Archer DF, Schreiber CA, Teal S, Westhoff C, Dart C, Blithe DL: Emergency contraception for individuals weighing 80kg or greater: a randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel. Contraception 23:110474, Apr 2024.
Mauck C, Thurman A, Jensen JT, Schreiber CA, Baker J, Hou MY, Chavoustie S, Dart C, Wu H, Ravel J, Gajer P, Herold BC, Jacot T, Zack N, Hatheway J, Friend D: Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive. Contraception 27:110440, Mar 2024.
Chesnokova AE, Nagendra D, Dixit E, McAllister A, Schachter A, Schreiber CA, Roe AH, Sonalkar S: Trust in provider and stigma during second-trimester abortion. Sex Reprod Healthc 39:100932, Mar 2024.
Krashin JW, Black P, Brannen E, Gard CC, Lin Y, Greenwood-Ericksen M, Trujillo VY, Burkhardt G, Schreiber CA.: Geographic Access to Early Pregnancy Loss Management. Obstet Gynecol 143: 435-439, Mar 2024.
Lee IT, Senapati S, Schreiber C, Koelper N, Takacs P, Barnhart K: Application of a Multiplex Platform to Identify Novel Biomarkers for Pregnancy Location and Viability. Res Sq rs.3.rs-2777020, May 2023 *preprint.
Gutman S, Connor H, Mumford SL, Gilmore E, Roe AH, Schreiber CA: Feasibility and acceptability of virtual group contraceptive counseling prior to abortion care. Contraception 126:110114, Oct 2023.